Viewing Study NCT02962505


Ignite Creation Date: 2025-12-25 @ 3:26 AM
Ignite Modification Date: 2026-02-28 @ 7:11 PM
Study NCT ID: NCT02962505
Status: COMPLETED
Last Update Posted: 2019-03-21
First Post: 2016-11-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Continuous Regional Analysis Device for Neonate Lung
Sponsor: University Hospital Schleswig-Holstein
Organization:

Study Overview

Official Title: Continuous Regional Analysis Device for Neonate Lung
Status: COMPLETED
Status Verified Date: 2019-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: CRADL
Brief Summary: The purpose of the study is to assess whether Electrical Impedance Tomography (EIT) has the potential to optimize the ventilator therapy, validate the effectiveness, efficacy and safety of nursing and medical interventions (endotracheal suctioning, posture changes, surfactant therapy, recruitment manoeuvres, etc.) and for early recognition of complications like pneumothorax and endotracheal tube misplacement. The study design is purely observational.
Detailed Description: EIT data will be recorded during 72 hours of routine clinical treatment. To prevent any decisions based on EIT information, the clinicians will be blinded to the EIT findings during the study period. Data on clinical interventions and clinical findings will be recorded using a specially adapted graphical user interface on the EIT device in combination with a paper-based case report form (CRF). EIT data analysis will be performed off-line.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: